Ted D Kellner - 17 Jul 2025 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Role
Director
Signature
/s/ Ted D Kellner
Issuer symbol
AIMI
Transactions as of
17 Jul 2025
Net transactions value
$0
Form type
4
Filing time
21 Jul 2025, 16:10:22 UTC
Previous filing
23 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KELLNER TED D Director C/O T&M PARTNERS, 790 N. WATER ST., #2175, MILWAUKEE /s/ Ted D Kellner 21 Jul 2025 0001187524

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AIM Common Stock 34,255 17 Jul 2025 By Kelvest LP F1, F2
holding AIM Common Stock 2,700 17 Jul 2025 By Beta Fund Investment Club F3
holding AIM Common Stock 250 17 Jul 2025 By Kellner,Ted Combined Profit Sharing/Money Purchase Plan F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person transferred all of his shares owned beneficially to Kelvest I LP. The shares listed here include these shares.
F2 Shares held by Kelvest I LP, for which the reporting person serves as Manager of T&M Partners LLC, General Partner of Kelvest I LP.
F3 Shares held by the Beta Fund Investment Club, for which the reporting person serves as the manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F4 Shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee.